1. Jia L, Quan M, Fu Y, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19(1):81-92.
  2. Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease. Alzheimers Dement. 2020;16(1):178-191.
  3. Quan M, Zhao T, Tang Y, et al. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease. Alzheimer’s research & therapy. 2020;12(1):14.
  4. Zhang J, Yue X, Luo H, et al. Illumination with 630 nm Red Light Reduces Oxidative Stress and Restores Memory by Photo-Activating Catalase and Formaldehyde Dehydrogenase in SAMP8 Mice. Antioxid Redox Signal. 2019;30(11):1432-1449.
  5. Zhang J, Chen B, Lu J, et al. Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer’s pathologies. Aging Cell. 2019;18(4):e12978.
  6. Xu LZ, Li BQ, Jia JP. DAPK1: a Novel Pathology and Treatment Target for Alzheimer’s Disease. Mol Neurobiol. 2019;56(4):2838-2844.
  7. Wang W, Hou TT, Jia LF, et al. Toxic amyloid-beta oligomers induced self-replication in astrocytes triggering neuronal injury. EBioMedicine. 2019;42:174-187.
  8. Tang Y, Xing Y, Zhu Z, et al. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomized controlled trial. Alzheimers Dement. 2019;15(5):605-614.
  9. Jia L, Qiu Q, Zhang H, et al. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15(8):1071-1080.
  10. Wang ZH, Gong K, Liu X, et al. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease. Nat Commun. 2018;9(1):1784.
  11. Jia J, Wei C, Chen S, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483-491.
  12. Jia J, Gauthier S, Pallotta S, et al. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer’s disease. Alzheimers Dement. 2017;13(5):592-597.
  13. Ikram MA, Bersano A, Manso-Calderón R, et al. Genetics of vascular dementia – review from the ICVD working group. BMC Med. 2017;15(1):48.
  14. Ma Q, Zhao H, Tao Z, et al. MicroRNA-181c Exacerbates Brain Injury in Acute Ischemic Stroke. Aging Dis. 2016;7(6):705-714.
  15. Jia J, Zuo X, Jia XF, et al. Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimers Dement. 2016;12(4):446-453.
  16. Jia J, Wei C, Liang J, et al. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial. Alzheimers Dement. 2016;12(2):89-99.
  17. Zhang Z, Song M, Liu X, et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat Commun. 2015;6:8762.
  18. Tang Y, Wang X, Jia J. Mercury poisoning presenting as sporadic Creutzfeldt-Jakob disease: a case report. Ann Intern Med. 2015;162(6):462-463.
  19. Meng R, Ding Y, Asmaro K, et al. Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment. Neurotherapeutics. 2015;12(3):667-677.
  20. Mei Y, Jiang C, Wan Y, et al. Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline. Aging Cell. 2015;14(4):659-668.
  21. Jia J, Zhou A, Wei C, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439-447.
  22. Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 2014;10(1):1-9.
  23. Xing Y, Jia JP, Ji XJ, et al. Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer’s disease. PROGRESS IN NEUROBIOLOGY. 2013;111:53-74.
  24. Wang J, Zuo X, Dai Z, et al. Disrupted functional brain connectome in individuals at risk for Alzheimer’s disease. Biol Psychiatry. 2013;73(5):472-481.
  25. Leak RK, Zhang L, Luo Y, et al. Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury. Stroke. 2013;44(4):1124-1134.
  26. Meng R, Asmaro K, Meng L, et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012;79(18):1853-1861.
  27. Gauthier S, Wu L, Rosa-Neto P, et al. Prevention strategies for Alzheimer’s disease. Transl Neurodegener. 2012;1(1):13.
  28. Shi FD, Jia JP. Neurology and neurologic practice in China. Neurology. 2011;77(22):1986-1992.
  29. Qin W, Jia L, Zhou A, et al. The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer’s disease. Aging Cell. 2011;10(4):711-719.
  30. Han Y, Wang J, Zhao Z, et al. Frequency-dependent changes in the amplitude of low-frequency fluctuations in amnestic mild cognitive impairment: a resting-state fMRI study. Neuroimage. 2011;55(1):287-295.
  31. Tang Y, Wang X, Ding Y, et al. Longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease. J Neurol Neurosurg Psychiatry. 2010;81(8):941-942.
  32. Zhou W, Xu D, Peng X, et al. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma. 2008;25(4):279-290.
  33. Liu Z, Jia J. Novel human pathological mutations. Gene symbol: PRNP. Disease: dementia. Hum Genet. 2007;122(5):545.
  34. Zhou J, Meng R, Sui X, et al. Effects of administration styles of arsenic trioxide on intracellular arsenic concentration, cell differentiation and apoptosis. Haematologica. 2005;90(9):1277-1279.
  35. Jia J, Pollock M. Cold injury to nerves is not due to ischaemia alone. Brain. 1998;121 ( Pt 5):989-1001.
  36. Jia J, Pollock M. The pathogenesis of non-freezing cold nerve injury. Observations in the rat. Brain. 1997;120 ( Pt 4):631-646.